Nichi-Iko Pharmaceutical: Nichi Iko Pharmaceutical : DelayedConsolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2022 (IFRS)
(marketscreener.com) Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2022 November 12, 2021 ...https://www.marketscreener.com/quote/stock/NICHI-IKO-PHARMACEUTICAL-6814872/news/Nichi-Iko-Pharmaceutical-12308-Delayed-12309-Consolidated-Financial-Results-for-the-Second-Quar-37200088/?utm_medium=RSS&utm_content=20211203
Read full article »
President & CEO
Yuichi Tamura
Nichi-Iko Pharmaceutical engages in manufacturing and commercializing prescription drugs issued by hospitals, clinics, pharmacies and drug stores.
Read more